FDA Drug Application (202088) for SUPRENZA by CITIUS PHARMS

Back to FDA Applications sponsored by CITIUS PHARMS

Application Number202088
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage15MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUPRENZA
Active IngredientPHENTERMINE HYDROCHLORIDE



Back to FDA Applications sponsored by CITIUS PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.